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Kuru is so far the principal human epidemic prion disease. While its incidence has steadily declined
since the cessation of its route of transmission, endocannibalism, in Papua New Guinea in the 1950s,
the arrival of variant Creutzfeldt–Jakob disease (vCJD), also thought to be transmitted by dietary
prion exposure, has given kuru a new global relevance. We investigated all suspected cases of kuru
from July 1996 to June 2004 and identiﬁed 11 kuru patients. There were four females and seven
males, with an age range of 46–63 years at the onset of disease, in marked contrast to the age and sex
distribution when kuru was ﬁrst investigated 50 years ago. We obtained detailed histories of residence
and exposure to mortuary feasts and performed serial neurological examination and genetic
studies where possible. All patients were born a signiﬁcant period before the mortuary practice of
transumption ceased and their estimated incubation periods in some cases exceeded 50 years. The
principal clinical features of kuru in the studied patients showed the same progressive cerebellar
syndrome that had been previously described. Two patients showed marked cognitive impairment
well before preterminal stages, in contrast to earlier clinical descriptions. In these patients, the mean
clinical duration of 17 months was longer than the overall average in kuru but similar to that
previously reported for the same age group, and this may relate to the effects of both patient age and
PRNP codon 129 genotype. Importantly, no evidence for lymphoreticular colonization with prions,
seen uniformly in vCJD, was observed in a patient with kuru at tonsil biopsy.
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1. INTRODUCTION
Kuru is one of the neurodegenerative diseases known as
the transmissible spongiform encephalopathies or prion
diseases. These diseases affect both animals and
humans. The animal prion diseases include scrapie, a
naturally occurring disease affecting sheep and goats,
that has been recognized for over 200 years and is
present in many countries worldwide, and the much
more recently recognized bovine spongiform encephalo-
pathy (BSE) among cattle. The human prion diseases
have been traditionally classiﬁed into Creutzfeldt–Jakob
disease (CJD), Gerstmann–Stra ¨ussler syndrome, fatal
familial insomnia and kuru. These diseases are experi-
mentally transmissible both within and between
mammalian species by inoculation with infected tissues
and sometimes by dietary exposure. The human prion
diseases have three distinct aetiologies: they may be
autosomal dominantly inherited conditions; acquired
from exposure to environmental prions (via diet or
accidental exposure during medical and surgical
procedures); or they may arise sporadically (Collinge
2001). Prion diseases are associated with the accumu-
lation of an abnormal, partially protease-resistant iso-
form of a host-encoded glycoprotein known as prion
protein (PrP) in the brain. The disease-related replicat-
ing isoform PrP
Sc is derived from its normal cellular
precursor (PrP
C) by a post-translational process that
involves conformational change and aggregation. Accor-
ding to the ‘protein-only’ hypothesis (Grifﬁth 1967), an
abnormal PrP isoform is the principal, and possibly the
sole, constituent of the transmissible agent or prion
(Prusiner 1982; Collinge & Clarke 2007).
While scrapie has been thought not to infect
humans, the large-scale epidemic of BSE in the UK
has posed a signiﬁcant threat to public health and
focused much attention on human prion disease. Since
1996, a new human prion disease, variant Creutzfeldt–
Jakob disease (vCJD), has been recognized in the UK
and experimental studies, involving both molecularand
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this is caused by the same prion strain as that causing
BSE in cattle (Collinge et al. 1996b; Bruce et al. 1997;
Hill et al. 1997a; Asante et al. 2002). There has been
widespread dietary exposure of the UK population to
BSE prions; the total cattle epidemic has been
estimated at approximately 2 million infected animals
(Donnelly et al. 2002). Cattle BSE has also been
reported in most member states of the European
Union, Israel, Switzerland, Canada, the USA and
Japan. To date, approximately 170 vCJD patients
have been recognized in the UK and approximately
30 cases from other countries including France, Italy,
The Netherlands, Ireland, Spain, Canada, Japan
and the USA. Predictions of the eventual size of the
vCJD epidemic, based on mathematical modelling and
the clinical cases of vCJD to date, though varying
widely, have suggested that the total epidemic may be
relatively small (Ghani et al. 2003). However, there are
many uncertainties, notably with respect to major
genetic effects on incubation period (Lloyd et al. 2001).
Moreover, these models have not estimated the
number of infected individuals, which may prove to be
the most important aspect of the vCJD epidemic. We
do not know the human infectious or lethal dose of BSE
prions by the oral or any other route, the cumulative
effect of multiple dosing or whether, in addition to
preclinically affected individuals, there are subclinical
carrier states of prion infection in humans, as
recognized in several animal models (Hill et al. 2000;
Asante et al. 2002; Thackrayet al. 2002; Hill & Collinge
2003). If so, this will prove to be a signiﬁcant problem
for secondary transmission of vCJD via medical and
surgical procedures performed on asymptomatic indi-
viduals incubating the disease. Importantly, the patho-
genesis of vCJD differs substantially from that of other
forms of CJD in that, unlike classical CJD, lympho-
reticular tissues, includinglymph nodes, are extensively
(and uniformly) involved with PrP
Sc levels in tonsil up
to 10% of those seen in the brain (Wadsworth et al.
2001). Four patients have now been identiﬁed with
vCJD prion infection from a small cohort of individuals
(currently approx. 23) known to have received blood
transfusion from a donor who subsequently developed
vCJD, suggesting that the transmission of vCJD prion
infection by this route may be relatively efﬁcient
(Llewelyn et al. 2004; Peden et al. 2004; Wroe et al.
2006;W r o eet al., unpublished data). A retrospective
study of archived surgical lymphoreticular specimens
(largely appendix) reported 3 out of 12 674 positive
for PrP immunoreactivity and estimated prevalence of
infection at 237 per million (95% conﬁdence interval
49–692 per million) (Hilton et al. 2004). Appendix
appears to be a less sensitive reporter of vCJD prion
infection than tonsil (Joiner et al. 2002), and this
retrospective study may therefore have underestimated
prevalence. A prospective national-scale anonymous
screen of discarded tonsillectomy tissue for PrP
immunoreactivity was announced by the Chief Medical
Ofﬁcer and is now underway to try to better estimate
prevalence of asymptomatic infection with vCJD prions
in the community. These concerns and uncertainties,
particularly with respect to the possibility of extremely
prolonged incubation periods of BSE in humans,
have renewed interest in kuru, which remains our
only experience of a major epidemic of human prion
disease, and from which there is much to be learned of
direct relevance to vCJD.
Kuru reached epidemic proportions in the people of
the Fore linguistic group and the neighbours with whom
they intermarried, living in the Eastern Highlands of
Papua New Guinea (Zigas & Gajdusek 1959). Local
oral history, recorded from when the disease was ﬁrst
studied by western medicine in 1957, dated the onset of
the ﬁrst cases to at least as far back as the 1920s. Kuru
predominantly affected women and children (of both
sexes), with only 2% of cases in adult males (Alpers
1987). Kuru was always fatal and, in affected villages,
was the commonest cause of death among women. It
was the practice in these communities to engage in the
consumption of dead relatives as a mark of respect and
mourning (transumption). Males over the age of 6–8
years participated little in mortuary feasting, which
explains the differential age and sex incidence. It is
hypothesized that the epidemic originated from the
consumption of a sporadic CJD case occurring in the
region some decades earlier (Alpers & Rail 1971).
Epidemiological studies provided no evidence for
vertical transmission, since most of the children born
after 1956 (when endocannibalism had effectively
ceased) and all of those born after 1959 of mothers
affected with or incubating kuru were unaffected (Alpers
1987;Collingeetal.2006).Fromtheageoftheyoungest
affected patient, the shortest incubation period is
estimated as 5 years, although it may have been shorter,
since the time of infection was usually unknown. The
age of onset of disease in kuru has ranged from 5 to over
60 years. The mean clinical duration of illness is 12
months with a range of 3 months to 2 years, though in a
few atypical cases it may be much longer; the course
tends to be shorter in children (Alpers 1964c).
The central clinical feature is progressive cerebellar
ataxia. In sharp contrast to classical CJD, dementia is
reported to be much less prominent and may be absent,
although in the later stages many patients have their
facultiesobtunded(Alpers1987).Theoccasionalcasein
which gross dementia occurs was thought to be in
marked contrast to the clinical norm. Kuru does not
appear to have changed in its features at different stages
of the epidemic reported to date and has a well-
characterized clinical progression with a distinct pro-
drome and three clinical stages. Kuru typically begins
with prodromal symptoms consisting of headache,
aching oflimbs and joint pains,which can last for several
months. This is followed by the onset of the ﬁrst, or
ambulatory, stage. Kuru was frequently self-diagnosed
by patients at the earliest onset of unsteadiness in
standing or walking, or of dysarthria or diplopia. At this
stage, there may be no objective signs of disease. Gait
ataxia, however, worsens and patients develop a broad-
based gait, truncal instability and titubation. A coarse
postural tremor is usually present and accentuated by
movement; patients characteristically hold their hands
together in the midline to suppress this. Standing with
feet together reveals clawing of toes to maintain posture.
This marked clawing response is regarded as pathogno-
monic of kuru. Patients often become withdrawn at this
stage and occasionally develop a severe reactive
3726 J. Collinge et al. Recent patients with kuru
Phil. Trans. R. Soc. B (2008)depression.Theprodromalsymptomstendtodisappear.
Astasia and gait ataxia worsen and the patient requires a
stickforwalking.Intentiontremor,dysmetria,hypotonia
and dysdiadochokinesis develop. Although eye move-
ments are ataxic and jerky, nystagmus is rarely seen.
Strabismus, usually convergent, may occur, particu-
larly in children. This strabismus does not appear to be
concomitant or paralytic and may ﬂuctuate in both
extent and type, sometimes disappearing later in the
clinical course. Photophobia is common and there may
be an abnormal cold sensitivity with shivering and
piloerection even in a warm environment. Tendon
reﬂexes are reduced or normal and plantar responses
are ﬂexor. Dysarthria usually occurs. The mean clinical
duration of the ﬁrst stage is approximately eight months
andcorrelatescloselywithtotalduration(Alpers 1964c).
Ataxia progresses and the loss of ability to walk without
support marks the transition from the ﬁrst (ambulatory)
stage to the second (sedentary) stage. Attempted
walking with support leads to a high-steppage, wide-
based gait with reeling instability and ﬂinging arm
movements in an attempt to maintain posture. Hyperre-
ﬂexia is seen, although plantar responses characteristi-
cally remain ﬂexor with intact abdominal reﬂexes.
Clonus is often marked though invariably short lived.
Athetoid and choreiform movements and parkinsonian
tremors may occur. There is no paralysis, although
muscle power is reduced. Obesity is common at this
stage but may be present in early disease associated with
bulimia. Characteristically, there is emotional lability
and there may be euphoria with inappropriate laughter,
which has led to the disease being referred to as the
‘laughing death’. There is no sensory impairment. In
sharp contrast to CJD, myoclonic jerking is rarely seen.
This stage typically lasts approximately two to three
months. When truncal ataxia reaches the point where
the patient is unable to sit unsupported, the third or
recumbent stage is reached. Hypotonia and hyporeﬂexia
develop and the terminal state is marked by a ﬂaccid
muscle weakness. Plantar responses remain ﬂexor and
abdominal reﬂexes intact. Progressive dysphagia occurs
and patients become incontinent of urine and faeces.
Inanition and emaciation develop. Transient conjugate
eye signs and dementia may occur. Primitive reﬂexes
develop in occasional cases. Brainstem involvement and
both bulbar and pseudobulbar signs occur. Respiratory
failure and bronchopneumonia or septicaemia even-
tually leads to death. The tertiary stage typically lasts
one to two months, though prolongation of the terminal
moribund state is not uncommon.
Transmission of CJD in western societies has
occurred by accidental inoculation with human prions
as a result of medical and surgical procedures. Such
iatrogenic routes, which may be considered a western
counterpart of cannibalism, include the use of inade-
quately sterilized neurosurgical instruments, dura
mater and corneal grafting, and intramuscular injection
with human cadaveric pituitary-derived growth hor-
mone or gonadotrophin. Most recently, cases of
iatrogenic infection with vCJD prions arising from
blood transfusion have emerged (Llewelyn et al. 2004;
Peden et al. 2004; Wroe et al. 2006). Interestingly,
cases arising from intracerebral or optic inoculation
manifest clinically as classical CJD, with a rapidly
progressive dementia, while those resulting from periph-
eral inoculation, most notably following cadaveric
pituitary-derived growth hormone exposure, typically
present with a progressive cerebellar syndrome, and are
in that respect somewhat reminiscent of kuru. There-
fore, one possibility is that the route of infection is an
important determinant of kuru phenotype, although
prion strain type and host genetic background are also
likely to be important factors.
Kuru was extensively studied at its peak in the late
1950s and the early 1960s and monitoring was
continued through the Institute of Human Biology
(later, Papua New Guinea Institute of Medical
Research (PNGIMR)) from the late 1960s and by the
ﬁeld team established by M.P.A. in the early 1970s,
later incorporated into the ﬁeld team of the PNGIMR,
which has maintained surveillance continuously since
then. We strengthened active surveillance in 1996 and
aimed to study all kuru patients until the end of the
epidemic. In particular, we wished to determine the
maximum incubation periods possible in human prion
infection, now estimated to be more than 50 years
(Collinge et al. 2006). The effective prohibition of
endocannibalism by the Australian authorities in the
mid-1950s led to the abrupt cessation of transmission
of kuru, which allows a unique opportunity to
investigate the incubation period, a key parameter in
human prion disease. We investigated whether any
remaining sources of infection persisted, including any
evidence of maternal or other routes of kuru trans-
mission, and sought to compare the clinical and other
diagnostic features of kuru with the other acquired
human prion diseases, iatrogenic CJD and vCJD,
which show a number of similarities to kuru.
Kuru also provides a unique opportunity to charac-
terize genetic susceptibility and resistance factors and to
gain insights into the peripheral pathogenesis of orally
acquired prion disease in humans. Genetic susceptibility
is signiﬁcant in both the sporadic and acquired forms of
humanpriondisease.Thereisacommonpolymorphism
in human PrP, with either methionine or valine present
at residue 129. In Europeans, approximately 38% are
homozygous for the more frequent methionine allele,
51% are heterozygous and 11% homozygous for valine.
The large majorityofsporadic CJD occurs inindividuals
homozygousfor thispolymorphism(Palmer etal.19 91 ).
This susceptibility factor is also relevant in the acquired
forms of CJD, most strikingly in vCJD, where all clinical
cases studied to date have been PRNP codon 129
methionine homozygous (Collinge et al. 1991, 1996a).
The PRNP codon 129 genotype has a signiﬁcant effect
on kuru incubation periods and susceptibility, and the
most elderly survivors of the kuru epidemic are
heterozygous (Cervenakova et al. 1999; Mead et al.
2003). The marked survival advantage for those
heterozygous at codon 129 provides a powerful basis
for selection pressure in the population affected by kuru.
Remarkably, an analysis of the worldwide haplotype
diversity and allele frequency of PRNP coding and non-
coding polymorphisms suggests that balancing selection
at this locus is not restricted to the Fore but is much
older and more geographically widespread. Evidence for
balancing selection (where there is more variation than
expected in a gene due to heterozygote advantage)
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Given recent biochemical and physical evidence of
cannibalism on ﬁve continents, one explanation is that
cannibalism resulted in a series of prion disease
epidemicsinhumanprehistory,thusimposingbalancing
selection on PRNP (Mead et al.2 0 0 3 ).
Wealsosoughttoprovidefurtherdatafor theaccurate
epidemiological modelling of the kuru epidemic and to
document mortuary feast practices and traditional
beliefs of the aetiology of kuru by interview of surviving
participants and other members of the Fore community;
here we report our clinical studies and investigation of
PRNP in recent kuru patients.
2. MATERIAL AND METHODS
(a) Research ethics
The clinical and laboratory studies were approved by the
Medical Research Advisory Committee of the Government of
Papua New Guinea and by the local research ethics
committees of St Mary’s Hospital and the Institute of
Neurology and National Hospital for Neurology and
Neurosurgery in London. Critically important from both
the ethical and operational aspects was the full participation
in the project of the communities involved. This was
established and maintained through discussions with village
leaders, communities, families and individuals. The ﬁeld
studies followed the principles and practice of the PNGIMR,
in collaboration with which this study was performed.
(b) Kuru surveillance and clinical studies
A ﬁeld base and basic laboratory for sample processing and
storage was established in the village of Waisa in the South
Fore. A team of local kuru reporters communicated to the
ﬁeld base the details of any person suspected of suffering from
kuru. The large majority of these suspect cases would not be
conﬁrmed as kuru on subsequent investigation by the ﬁeld
team or the visiting Medical Research Council (MRC) Unit
medical staff; 50 suspect cases investigated during this period
proved not to have kuru. The ﬁeld team comprised MRC,
PNGIMR and local staff, and undertook regular ﬁeld patrols
throughout the kuru-affected area, which includes the North
and South Fore, Keiagana, Kanite and Gimi linguistic
groups. The ﬁeldwork involved walking in arduous terrain
in poor weather conditions at high altitude in the Eastern
Highlands Province. Roads were frequently impassable and
getting supplies to the ﬁeld, and samples from it, often needed
heavy-vehicle rescue equipment and a large team. Security
issues intermittently affected our ability to travel to and from
the ﬁeld site. Regular ﬁeld neurological examinations were
performed when possible (by J.C., M.P.A. or D.T.) and
patients’ clinical features were documented by ﬁlming on
video and by still photography. Case histories and exposure to
mortuary feasts were documented. Venous blood samples
were taken for molecular genetic studies from patients and,
where possible, from family and community members.
(c) Tonsil biopsy
With informed consent from the patient and his family, tonsil
biopsy was performed at Goroka General Hospital by one of
us (A.F.), with assistance from local medical staff using
disposable instruments, as previously described (Hill et al.
1999). A portion of the tonsil tissue was ﬁxed in 10% formol
saline and the rest shipped frozen on dry ice to London for
analysis. PrP immunohistochemistry was performed using
anti-PrP monoclonal antibody ICSM 35 (D-Gen Ltd,
London) and Western blot analysis for PrP
Sc performed as
previously described (Wadsworth et al. 2001).
(d) Molecular genetic studies
The methodology used was as previously described (Mead
et al. 2001). In brief, genomic DNA was extracted from
venous blood and the complete coding sequence of the prion
protein gene (PRNP) determined by the direct sequencing of
the polymerase chain reaction (PCR)-ampliﬁed open reading
frame. Restriction endonuclease digestion of PCR amplicons
was used to analyse the apolipoprotein E gene (APOE) and
the prion-protein-like protein gene (PRND). The ABI SDS
7000 sequence detection system was used for the allelic
discrimination of PRNP codon 129 and PRNP haplotypes.
HLA-DQB1 alleles were determined by the automated
ﬂuorescent sequencing of PCR amplicons using the
Amersham MegaBACE DNA analysis system.
3. RESULTS
Since July 1996 to the end of June 2004, we identiﬁed
11 kuru patients. The sex, age of onset and duration of
disease of all patients are given in table 1. Age is not
usually accurately known in these communities but can
be reliably estimated by reference to family relation-
ships and historical events (Alpers 1964a). The area
and linguistic groups historically affected by kuru are
illustrated in ﬁgure 1. Figure 2 locates all the villages
that have had a historyof kuru and shows the shape and
extent of the kuru region. All patients identiﬁed in the
current study were from the South Fore, kuru now
having disappeared from the North Fore and other
linguistic groups to the north. The 11 patients were
from 10 villages, as shown in Collinge et al. (2006);
there were two patients from Kamira, which since 1957
has had more patients than any other village.
Of the 11 patients, four were female and seven male.
The age of onset ranged from 46 to 63 years. The ages
at death included two in their 40s, ﬁve in their 50s and
four in their 60s. These distributions are strikingly
different from those found when kuru was ﬁrst analysed
(Zigas & Gajdusek 1959; Gajdusek et al. 1961; Alpers
1964a; Alpers & Gajdusek 1965): 60% of the cases in
adult women, with the remainder mostly in children
and adolescents of both sexes. In 1957–1958, the
proportion of cases in adult males was 2%; this
percentage gradually rose as the disease died out in
children and adolescents, but the numbers of adult
male deaths from kuru were never high (Alpers 1987).
The demography of the South Fore in 1962 (Alpers &
Gajdusek 1965) showsthat in a population of7224, 6%
of males and 4% offemales were aged 50 years or more.
These percentages are low but consistent with the life
expectancy of a traditional society; the difference is
one example of the effect that kuru had on the Fore
demography (by comparison, the corresponding
ﬁgures for the 2001 population of the UK are 31 and
35%). The major perturbation of the demography by
kuru was in the male:female ratio of the population:
1.64 in the South Fore in 1962 (in the UK it is 0.95).
Despite the relatively small proportion of older people
in the population, in the 7-year period of 1957–1963,
out of 1254 deaths from kuru, 203 were in females aged
40 years or more (Alpers 1979), including 54 in their
50s and 19 in their 60s. In striking contrast, there were
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(Alpers 1979). Since both of these deaths occurred in
1962, all maleswho died of kuru before 1962 were aged
less than 40 years (unpublished data from the kuru
epidemiological database).
The duration of the disease from the onset of kuru to
death varied in the 11 patients from 10 to 25 months.
The mean was 17 months and standard deviation (s.d.)
5 months. This is consistent with earlier ﬁndings
(Alpers 1964c) and the established range of 3–23
months found in 1962–1963, except that there were no
cases of short duration. The mean is consequently
higher than the 12.5 months (s.d. 5 months) previously
found; however, since that study included all ages and
showed that duration tended to lengthen with age, the
present ﬁnding in patients with a mean age of onset of
55 years is not exceptional.
The clinical features of contemporary kuru patients
are exempliﬁed by the following case histories.
(a) Patient AKA
Male patient of age estimated at 48 years was ﬁrst
examined in June 1997. At that time, he had a seven-
month historyoffeeling inappropriately cold, ﬁrstin his
lower limbs and then becoming generalized. He had
noted progressive unsteadiness in walking during this
period. There was no limb or joint pain, stiffness or
weakness. He described frequent headaches with their
onset in the afternoon. At this stage, the patient
attributed his illness to chronic malaria, although
relatives and community members suspected kuru.
He was otherwise well and taking no medication.
He was born in the South Fore and spent his child-
hood there in two villages severely affected by kuru.
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Figure 1. The area and linguistic groups historically affected by kuru in the Eastern Highlands Province of Papua New Guinea.
Table 1. Illness duration, PRNP genotype and estimation of incubation period in 11 recent kuru patients (Patients’ initials are
based on name and coded. M, methionine; V, valine; n.a., not available.).
patient sex
year of
birth onset
age at
onset death
age at
death
duration
of illness
(months)
PRNP
genotype
likely
a
incubation
period (years)
YAK male 1948 Nov 1994 46 Dec 1996 48 25 MV 39
PKW female 1946 Aug 1995 49 Dec 1996 50 16 MV
MWK male 1933 Apr 1996 63 Apr 1997 64 12 MM 56
AKA male 1949 Nov 1996 47 Jul 1998 49 20 MV 40
AYY male 1940 Jun 1998 58 Apr 2000 60 22 MV 51
AYA male 1936 Nov 1998 62 Nov 1999 63 12 n.a. 55
WKW male 1943 Jan 1999 56 Jun 2000 57 17 MV 49
TAM female 1945 Mar 1999 54 Jan 2000 55 10 VV
MAA female 1944 Apr 1999 55 Jan 2001 57 21 MV
INO female 1942 Jan 2000 58 May 2001 59 16 MV
KAW male 1943 Oct 2001 58 Apr 2003 60 18 MV 51
aAs males are unlikely to have become infected after the age of 6–8 years (see text), a conservative estimate of the likely minimum incubation
period can be calculated as the number of years from age 7 to disease onset.
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community conﬁrmed his participation in multiple
mortuary feasts as a child with his mother. His father
had died of an arrow injury and his mother died of kuru
in 1953 at the age of 23. He was then adopted and lived
with his foster parents until 1962 when he lived in the
male house until its closure in 1972. He worked on a
copra plantation in East New Britain Province before
returning to the highlands in 1976 and worked as a
storekeeper in Goroka until 1980. He then worked for
the local coffee company until the onset of his illness.
He had a sister who was well with six children. He was
married with one adopted child.
On examination in his village, he was alert,
orientated and fully cooperative with appropriate
affect. No pathological laughter was noted. He sat
with hands held tightly together, suppressing involun-
tary movements. There was titubation. He was
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Figure 2. Map showing the location of all villages that have had a history of kuru. Of the 172 village names on the map, 155
appear in the database of patients recorded since kuru surveillance began in 1957; however, only 145 of these villages have had
conﬁrmed cases during this time. Over 80% of all the recorded cases have occurred among the Fore linguistic group (South and
North Fore combined). Map derived from Gajdusek et al. (1961), Alpers (1964a), Alpers and the Kuru Surveillance Team
(Alpers 2005) and the kuru database (created by M.P.A., Judith Farquhar, Steven Ono and D. Carleton Gajdusek, and
maintained by M.P.A.).
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diplopia and visual pursuit was smooth without
nystagmus. There was no facial weakness and the
pupils were symmetrically responsive to light and
accommodation. He was restless with some choreiform
movements of upper limbs.There was no rest tremor or
fasciculation. Tone and power were normal in the limbs
and Romberg’s sign was negative. Tendon reﬂexes were
symmetrical and not brisk and plantar responses ﬂexor.
He had moderate impairment of ﬁnger–nose coordi-
nation in the upper limbs and dysdiadochokinesis.
Sensation was intact to touch and proprioception was
intact. His gait was somewhat wide based and tandem
gait markedly impaired. He was unsteady on one foot
with marked toe clawing. A clinical diagnosis was made
of ambulatory (stage 1) kuru. PRNP analysis demon-
strated normal coding sequence and the codon 129
genotype was methionine/valine heterozygous.
Following informed consent, the patient was
transferred to Goroka General Hospital for further
review and tonsil biopsy. When examined in November
1997, he remained in stage 1 (ambulatory) kuru.
Despite full insight into his condition and prognosis,
his mood was elevated with some evidence of euphoria.
His astasia, gait ataxia and upper limb incoordination
had worsened, but otherwise his clinical signs had not
signiﬁcantly changed over the intervening ﬁve months.
He was still able to walk without support and noted
himself the unusually slow progression. Tonsil biopsy
was performed.
By February 1998, he had lost the ability to walk
without support and, 15 months after onset, therefore
moved into the second (sedentary) stage of the disease.
This progressed over the next three months, and, by
May 1998, he was unable to sit up without support and
was considered to have entered the third (recumbent)
stage of kuru; two months later, he died following
a total illness duration of 20 months. No autopsy
was performed.
(b) Patient AYY
Malepatientof ageestimatedat60yearswhenexamined
in his village in February 2000. His symptoms began in
June 1998 when he noted interphalangeal foot pain on
walking, initially on the right and then bilaterally. He
noted unsteadiness in walking and complained of cold
feet and shivering despite warm conditions. There was
no headache. By December 1999, he was unable to walk
without active support and had developed poor memory
and was unable to recognize his house or names of close
relatives even when present. There was a past history of
malaria. He was taking no medication. He was born in
1940 and lived in the South Fore continuously
throughout the period endocannibalism was practised.
Local oral history from older members of the commu-
nity conﬁrmed his participation in multiple mortuary
feasts as a child. His brother died of kuru in 1952 at the
age of 17.
On examination, he was thin. Cognitive exami-
nation was limited by linguistic and cultural factors.
However, he was orientated to person, but not to time
or place. He was unable to recall any of three objects.
He did not have signiﬁcant problems with praxis and
was able to copy hand movements. There was
cerebellar dysarthria. Eye movements were full without
diplopia, but pursuit was broken. There was no
nystagmus and pupils responded to light and accom-
modation. Cranial nerves were otherwise intact. There
was no wasting of the limbs and no rest or postural
tremor, myoclonus or other involuntary movements.
Tone was normal and power full in the limbs. There
was marked cerebellar ataxia of all four limbs with
gross intention tremor and marked dysdiadocho-
kinesis. Tendon reﬂexes were present and symmetrical
but present at the ankles only on reinforcement. Plantar
responses were ﬂexor. Vibration sense was absent in
both the lower limbs to the hips bilaterally but pinprick
was intact with hyperaesthetic arms. Joint position sense
was intact. He was able to sit up without assistance but
walking required the support of two assistants. There
was marked truncal ataxia and a broad-based gait. Toe
clawing was absent. Cardiovascular examination was
normal witha blood pressureof 100/70 without postural
drop. There was no organomegaly. A clinical diagnosis
of second stage (sedentary) kuru was made. PRNP
analysis was performed and demonstrated normal
coding sequence and the codon 129 genotype was
methionine/valine heterozygous. He died at the age of
60 following a total disease duration of 22 months.
(c) Patient WKW
Male patient of age 57 years when examined in the
village in February 2000. He developed headache and
abdominal pain in January 1999. There were two
episodes of occipital headache with mandibular and
right ear pain. He also developed joint pains, starting in
the knees and associated with stiffness and then also
involving the upper limbs and the hands during the
second episode of headache. He developed unsteadi-
ness of gait and began to lose weight. In October 1999,
he developed diplopia, dysphasia and experienced
memory difﬁculties. By January 2000, he was unable
to walk unsupported. At the time of examination in
February 2000, family members reported that he was
forgetting the identity of close family members, but was
able to recognize them when present. He was taking no
medication. There was no past medical history of note.
He was resident in the South Fore throughout his
childhood. There was no immediate family history of
kuru. Local oral history from older members of the
community conﬁrmed his participation in multiple
mortuary feasts as a child.
On examination, he was able to understand requests
in Tok Pisin (the lingua franca of Papua New Guinea)
but reverted to his native Fore language in replies.
Cognitive testing was limited by linguistic and cultural
factors. However, he was orientated to name, but not to
time or place. He was unable to recognize his own
house in the village. He was able to repeat and recall
two of three objects. He was unable to count or copy a
drawing of a ﬂower or house, although such cognitive
testing may be of limited validity in a Fore individual
of this age. He was able to complete a three-stage
command and name the local representative and
missionary at a nearby larger village. He was able to
copy simple hand movements and a salute. There was
marked perseveration. Affect appeared normal with
appropriate laughter. There was no astereognosis; he
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vegetables by hand with eyes closed. There was bilateral
pout reﬂex, but palmomental and grasp reﬂexes were
absent. He had a brisk jaw jerk. He was examined
in bright light in the village and pupils were small but
symmetrical. There was an equivocal light response
but deﬁnite response to accommodation. Eye move-
ments were full, but pursuit jerky. There was no
nystagmus or diplopia and visual ﬁelds were intact
to confrontation. There was reduced left trigeminal
sensation to touch and pinprick and reduced left
corneal response. There was no facial weakness, and
hearing, palatal movement and tongue movements were
normal. Limbs were generally thin with fasciculation
of medial thighs bilaterally. There was no wasting of the
small muscles of the hand. There was no myoclonus,
restor postural tremor. There was nodystonic posturing
but there was marked clawing of the toes while standing.
There was extrapyramidal increase in tone in both
arms, left greater than right. Limb power was normal
with the exception of mild weakness (4/5) in ﬁnger
abduction. There was bilateral cerebellar ataxia of the
upper and lower limbs and more marked truncal ataxia.
Tendon reﬂexes were generally depressed but obtained
on reinforcement except at ankle. Plantar responses
were ﬂexor. He was able to sit up without assistance but
required two assistants to walk. Gait was then broad
based and symmetrical. Romberg’s test was negative
standing and sitting. There was loss of vibration sense
in both the lower limbs to the hips but joint position
sense and pinprick were preserved. Cardiovascular
examination was normal with a blood pressure of
90/70 without postural drop. There was no organome-
galy. A clinical diagnosis of second stage (sedentary)
kuru was made. PRNP analysis was performed and
demonstrated normal coding sequence and the codon
129 genotype was methionine/valine heterozygous. He
died at the age of 57 following a total disease duration of
17 months.
(d) Patient MAA
Female patient aged 56 years when examined in the
village in August 2000. Her symptoms began in April
1999 with leg pain, joint pain in her knees and difﬁculty
walking; she had been seen brieﬂy the following month
as possibly suffering from kuru. Her speech and vision
had been normal. There was no past medical history of
note and she was taking no medications. Her father had
been killed by ‘friendly ﬁre’during clan ﬁghting, which
led to her mother, then pregnant with her, ﬂeeing to a
neighbouring linguistic group, where she was born and
grew up. She visited her paternal village in the South
Fore with her mother during childhood and moved
back there at her marriage. Her mother died in the
adoptive community but the cause was not known to
her or her relatives. She had two husbands, both of
whom died, one of an unknown illness and the other
probably of liver cancer. She had seven children, all of
whom are alive and well, and four grandchildren.
Onexamination,shewascheerfulandrespondedwell
to questioning. She was mildly euphoric. There was no
emotional lability or gross cognitive impairment. There
was no dysphasia. Cranial nerves were intact. Eye
movements were not jerky and there was no diplopia
or nystagmus. Titubation was present. The limbs were
hypertonic with jerky rigidity, pipe-like in quality, noted
equally in both arms. There was no dysmetria in the
upper limbs, intention tremor or dysdiadochokinesis.
Heel–shin testing was performed well until the feet
came together in the midline. Tendon reﬂexes were
uniformly diminished and plantar responses ﬂexor. She
showed truncal instability but no Rombergism. No
sensory abnormality was detected and proprioception
was normal.
Her gait was wide based and severely ataxic but she
was able to walk independently if supported by a stick.
There was marked astasia with clawing of her toes.
A clinical diagnosis of stage 1B kuru was made (stage 1
can be subdivided into 1A where the patient can walk
entirely unaided, and 1B if a stick is necessary to walk).
At the very end of the ﬁrst stage of kuru, she showed
clear evidence of fully established midline cerebellar
disease and some extrapyramidal features. Unusually,
there were no signs at that time of neocerebellar
involvement. The ﬁrst stage of kuru lasted 17 months.
PRNP analysis demonstrated normal coding sequence
and the codon 129 genotype was methionine/valine
heterozygous. Her disease progressed quite rapidly over
the next ﬁve months until she died in January 2001.
Autopsy was not performed.
(e) Patient KAW
Male patient aged 58 years when seen in September
2001. He had experienced episodes of pain and
weakness in the legs for several years, which had
made walking difﬁcult; these had responded to local
treatment, which consisted of counterirritants, blood-
letting from the calf and herbal medicines, but then
recurred. He also had headaches and pain in the neck,
arms and thoracic and abdominal muscles. He was
convinced that these were ‘attacks of kuru’ and that he
was having such an attack when seen. When examined,
he was complaining of pain but was voluble and
relaxed, with no objective evidence of pain. He had
frequent fasciculations in his calf muscles. His posture
was steady, his stance ﬁrm and his gait normal. He
declined formal examination. Plasma electrolyte levels,
measured in the regional hospital in Goroka, were
normal. He was born in 1943 and lived in the South
Fore continuously during the period when traditional
mortuary feasts were held. His mother died of kuru in
1965, and local oral history from older members of the
community conﬁrmed his participation in multiple
mortuary feasts as a child.
During the next month, he went travelling within the
highlands. On his return, he complained of unsteadi-
ness of gait, which slowly worsened. During the next 10
months, he followed a progressive course with worsen-
ing cerebellar ataxia typical of kuru, and by the end of
August 2002 this had entered the second (sedentary)
stage. After three months, he was unable to sit without
support and became recumbent (stage 3 of kuru). He
alternated between periods of confusion and lucidity.
He still showed occasional fasciculations. He was
examined about a month after he became recumbent.
He waswell nourished and in no pain. He was lucid and
able to converse sensibly. He was calm and rational,
with some ﬂattening of affect. He had insight into his
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happen to his children after he died. He was continent
of urine and faeces and had no pressure sores. He had
severe photophobia. He had pronounced cerebellar
dysarthria. Eye movements were full but jerky; there
was no nystagmus. Cranial nerves were otherwise
intact. There were no abnormal facial movements or
dysconjugate eye movements. He was able to sit up
only with external support and had marked truncal
instability. His hands were held clasped in front to
suppress involuntary postural tremors. No fascicula-
tions were seen at this time. He had plastic, jerky
rigidity of all four limbs. His legs were weak. Power in
the arms and hands was also reduced to grade 3/5.
Tendon reﬂexes were diminished or absent; plantar
responses were ﬂexor. There was dysmetria in ﬁnger
and hand movements, intention tremor in ﬁnger–nose
alternation and dysdiadochokinesis. He performed all
these tests without hesitation or confusion.
Thereafter, his physical condition progressively
declined, with increasing weakness and disintegration
of movement. He became incontinent, developed
pressure sores in his sacral area, in both buttocks and
on both heels, and dislocated his left hip. He ate very
little and subsisted largely on sips of water. He was
unable to speak but continued to make eye contact and
followed people with his eyes. He persisted in this state
for another four months. In April 2003, he lost
consciousness for a day but by the next day had regained
the visual awareness of his surroundings and again
made eye contact, and the only movement was of his
eyes. He remained in this state for 3 days. He was totally
moribund the next day and died on the following day.
PRNP analysis demonstrated normal coding sequence
and the codon 129 genotype was methionine/valine
heterozygous. Autopsy was performed and the diagnosis
was neuropathologically conﬁrmed. A detailed descrip-
tion of the autopsy ﬁndings is given in Brandner
et al.( 2 0 0 8 ) .
(f ) Analysis of tonsil biopsy
It is of considerable interest as to whether kuru,
transmitted by dietary prion exposure, is associated
with tonsillar prion infection, as seen in vCJD, which is
also thought to be transmitted by dietary exposure,
but not in other forms of human prion disease. Tonsil
biopsy tissue was examined by PrP immunohistochem-
istry using anti-PrP monoclonal antibody ICSM 35
and no abnormal staining of follicular centres or other
areas was seen, in sharp contrast to vCJD tonsil
(Wadsworth et al. 2001; ﬁgure 3b). Western blot
analysis did not demonstrate PrP
Sc and remained
negative following high-sensitivity analysis involving
NaPTA precipitation from tissue homogenate to
concentrate any PrP
Sc present (Wadsworth et al.
2001; ﬁgure 3a).
(g) Incubation period estimation
These results have been reported by Collinge et al.
(2006). They are, however, presented and discussed
here in the context of the local mortuary practices and
epidemiological and clinical ﬁndings. The transmission
of the infectious prion of kuru occurred through the
endocannibalism (transumption) of dead relatives at
mortuary feasts held in their honour; our understanding
of this is based on a conjunction of experimental,
epidemiological and human behavioural evidence
(Alpers1968).Thepracticewasimportant to the people
as a way of respecting their dead, but it was rigorously
proscribed by the Australian government ofﬁcers in one
of their ﬁrst acts of administrative control after making
contact with the people. The Okapa Patrol Post was
established in 1954. Public consumption of the dead
ceased almost immediately and compliance was
ensured by the police force responsible for the
subdistrict. By 1956, endocannibalism was suppressed.
There were reports of surreptitious eating of the dead
in remote hamlets for some years afterwards, but by
1960 the practice had effectively ended; though after
this time a few dead bodies may have been exhumed
and partially eaten by older women determined to
maintain their proper respect for the dead, this would
not have had any epidemiological signiﬁcance since
such women would have had multiple previous
exposures. Epidemiological surveillance for kuru
began in 1957 and has been continued ever since
(Alpers 2005). Owing to the wide geographical extent
of the families involved in a feast, secret feasting
normal
brain
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Figure 3. Tonsil biopsy from patient AKA. (a) Immunoblot
analysed with anti-PrP monoclonal antibody 3F4 and
enhanced chemiﬂuorescence. Ten-microlitre aliquots of
10% normal human brain homogenate or 10% CJD brain
homogenate and 20 ml aliquots of 10% normal human tonsil
homogenate or 10% tonsil biopsy homogenate from a patient
with kuru were analysed before (PKK) or after (PKC)
proteinase K digestion. (b) Immunohistochemical analysis
with anti-PrP monoclonal antibody ICSM 35. The photo-
micrograph shows a lymphoid follicle with abnormal PrP
immunoreactivity being absent.
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undetected. The communities of the North Fore, who
had been the ﬁrst of the Fore people to lose their
traditional practices in the wake of Australian admin-
istrative control, ended their mortuary feasting at the
beginning of the decade or earlier; kuru is no longer
present in this area. The latest year of birth recorded for
any kuru patient is 1959. From this combination of
evidence, we can conclude that transmission through
the traditional mortuary practices had ceased by 1960.
This enables us to obtain a measure of minimum
incubation period as the time between 1960 and the
date of onset of kuru. The range of minimum
incubation period in the 11 patients was 34–41 years
(Collinge et al. 2006).
In males, after the age of 6–8 years, boys were taken
from their mother and brought up in the men’s house.
Fromthenon,theywereexposedonlytothesameriskas
adult males, who participated little in feasts and did not
eat the brain, by far the most infectious organ in kuru.
This can explain why in 1957–1958 adult males
contributed only 2 per cent to the total number of kuru
casesand,from what we now knowabout the incubation
period, most of these adult male cases would have been
fromtransmissionsintheirchildhood.This also explains
why all males dying of kuru before 1962 were aged less
than 40 years: those older would have been aged 6–8
years before 1930, when the epidemic was still slowly
building up and their childhood risk of exposure to
infection consequently small (females, by contrast, were
exposed at all ages throughout the epidemic). From the
male ages of exposure, we can estimate the likely
minimum incubation period of the males in the recent
group of patients described here as extending from the
year in which they turned 7 to the year of onset (and it
could possibly be up to 7 years longer). The range of
likely incubation period in the seven males in table 1 is
39–56 years. Compared with the UK population, the
peopleofthekururegion,evennow,havearelativelylow
life expectancy; hence, many long incubation cases of
kuruwouldhavediedofsomeothercauseandwouldnot
have been detected. The proportion of such cases
relative to those of shorter incubation period will
therefore be underestimated in the study described
here. Nevertheless, what we have been able to demon-
strate is the fact that incubation periods of this length do
occur in human prion diseases.
(h) Genetic analysis
Results of genetic analysis in these patients have been
reported elsewhere (Collinge et al. 2006) and are
summarized here and compared with those in the
healthy South Fore population. DNA was available for
analysis in 10 out of 11 kuru patients and 8 out of 10
were heterozygous at polymorphic residue 129 of PRNP
(table 1). Allele frequencies at PRNP 129 in 140
unrelated healthy South Fore were 129M (methionine;
48%) and 129V (valine; 52%). Although the majority of
the long incubation kuru cases were heterozygous, as
expected from the known protective effect of this
polymorphism, this distribution was not statistically
differentfromthecurrentnormalpopulationfrequencies
(c
2-test, pZ0.22). However, a comparison of clinical
duration of illness against codon 129 genotype is
interesting in that the two homozygous patients have
the shortest durations (10 and 12 months) when
compared with the eight heterozygotes. The clinical
durations for the two homozygous patients (10 and 12
months) fall 4.2 and 5.2 s.d. below the mean clinical
duration for heterozygous patients (mean 20.4 months
and s.d. 2.0 months). Although formal statistical tests
are not appropriate with only two observations, these
data support a modifying effect of codon 129 genotype.
The PRNP B haplotype has been associated with
susceptibility to sporadic CJD in the UK (Mead et al.
2001)a n dPRNP haplotyping was carried out in these
patients and in the normal Fore population. Nine single
nucleotide polymorphisms within 25 kb of PRNP
codon 129, identiﬁed in the European population, may
be used to predict PRNP haplotypes. Two common
haplotypes are found in the South Fore: 129M is
associated with haplotype F (haplotype frequency 40%)
and 129V with haplotype A (haplotype frequency 52%).
Haplotype B, known to be a common variant in Europe
andoverrepresentedinsporadicCJDpatients,wasfound
at a 3 per cent frequency in the South Fore. Albeit from
the analysis of a small sample size, the distribution of
PRNP haplotypes in the long incubation kuru patients
was not signiﬁcantly different from that in the healthy
South Fore population (c
2-test, pZ0.85).
As we have previously reported, allele frequencies at
the PRND codon 174 polymorphism, APOE and HLA-
DQB1 in these long incubation kuru patients were not
signiﬁcantly different from those in the current healthy
South Fore population, although, clearly, the number
of patients analysed was small (Collinge et al. 2006).
4. DISCUSSION
Epidemiologically,kuruisdeﬁnedbyitsessentialclinical
features of cerebellar ataxia, its subacute, progressive
course and its fatal outcome (Alpers 2005). Neuro-
pathological conﬁrmation was obtained in a small
proportion of cases in the past, but this was of major
signiﬁcance in characterizing kuru as a transmissible
spongiform encephalopathy (in fact, it was the key to
developing the concept of such a disease entity, once
transmission to the chimpanzee had been achieved;
Fowler & Robertson 1959; Hadlow 1959; Klatzo et al.
1959; Beck et al.1 9 6 6 ; Gajdusek et al.1 9 6 6 ). All the 11
recent patients in the present series were determined
throughthesameprocessofepidemiologicalsurveillance
as had been conducted in the past and the results are
therefore entirely consistent with case ascertainment
throughout the kuru epidemic. In one case, an autopsy
was obtained (which is a higher proportion than was
possible to achieve in the past). This gave neuropatho-
logical conﬁrmation of kuru, which is important in
validating the epidemiological and clinical ﬁndings
reported here. The autopsy enabled many other studies
to be undertaken, which will be reported separately.
While the clinical phenotype of these recent kuru
cases lies within the spectrum described for earlier
cases, there are some unusual features worthy of
comment. The average duration of illness (17 months)
is longer than that reported overall for earlier cases
(12.5 months) but is consistent with previous ﬁndings
of longer duration in older patients; in the previous
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patients aged 40 years or more the mean duration was
18 months (Alpers 1964c). Interestingly, however, the
two patients homozygous at PRNP 129 had signi-
ﬁcantly shorterclinical durations than the heterozygous
patients. Although this should be interpreted with
caution in view of the small numbers, it is possible that
the high mean duration overall in these cases of long
incubation period reﬂects an effect of PRNP hetero-
zygosity on disease duration. In sharp contrast to
sporadic CJD, dementia is not prominent in kuru and is
indeed characteristically thought to be absent until the
late or terminal stage of the disease (Zigas & Gajdusek
1957; Simpson et al. 1959;A l p e r s1964b, 1987;
Hornabrook 1968). However, two of the current
patients, who were both examined by two senior
neurologists, showed deﬁnite marked cognitive impair-
ment during stage 2 of the disease. While most formal
psychometric tests are linguistically and culturally
inappropriate for the Fore, and were therefore not
attempted, clinical evidence of multifocal dementia was
clearly elicited and has not been previously reported at
this relatively early stage in the disease progression,
although Alpers (1964b) reported disorientation in two
patients in the second stage of kuru. In two patients,
some sensory changes were reported, with loss of
vibration sense in the lower limbs, though joint position
sense and pinprick sensation were intact.
The dominant clinical feature of kuru is a progressive
cerebellar ataxia. While an ataxic onset is seen in some
patients with sporadic CJD, a rapidly progressive
cognitive impairment is the central feature. It is of
interest that iatrogenic CJD associated with peripheral
inoculationwithhumanprions(treatmentwithcontami-
nated pituitary growth hormone or gonadotrophin)
typically presents with ataxia, in sharp contrast to direct
CNS exposure by contaminated neurosurgical instru-
ments and dura mater grafting, where the phenotype is
generally of classical CJD. This led to suggestions that a
cerebellar onset may in part be determined by the route
of exposure. Consistent with such an explanation is that
in some rodent scrapie models, peripheral exposure is
followed by prion replication to high levels in lympho-
reticular tissues (Fraser et al.1 9 9 2 b), with later
neuroinvasion occurring by retrograde spread via
autonomic nerves with entry to the spinal cord and
then spread to the hindbrain including cerebellum
(Beekes et al. 1996). vCJD, in contrast to sporadic and
iatrogenic CJD, is uniformly associated with high levels
of prion colonization of the lymphoreticular tissues (Hill
et al. 1997b, 1999; Wadsworth et al. 2001), which has
also been detected preclinically in asymptomatic indi-
viduals(Hiltonetal.1998).Thismayalsoreﬂectrouteof
infection, presumed to be dietary, but could also be
determined by prion strain type. As part of our earlier
investigation of the diagnostic potential of tonsil biopsy
in human prion diseases (Hill et al. 1999), a tonsillar
biopsywasperformedon asinglekurupatient.Although
a single observation, the lack of any detectable PrP
Sc
using the highest sensitivity immunodetection methods,
during the clinical phase of the infection, argues against
there being substantial and uniform lymphoreticular
involvement as seen in all cases of vCJD studied, and
would be consistent with the prion strain properties of
vCJD determining the distinct peripheral pathogenesis
of vCJD rather than route of exposure. This observation
would suggest that secondary (iatrogenic) vCJD, arising
from parenteral rather than oral exposure to vCJD
prions, may also be associated with tonsillar infection
allowing early diagnosis by tonsil biopsy. This interpre-
tation is supported by positive tonsil analysis in a recent
blood transfusion-associated secondary case of vCJD
(Wroe et al. 2006).
The recognition of the similarities between kuru and
CJD (Klatzo et al. 1959) and, subsequently, scrapie
(Hadlow 1959) led to the experimental transmission of
kuru to primates (Gajdusek et al. 1966) and, 2 years
later, the transmission of CJD (Gibbs et al. 1968). This
identiﬁed the cluster of the transmissible spongiform
encephalopathies among diseases of the central
nervous system (CNS), which later developed into
the unifying concept of the mammalian prion diseases
(Prusiner 1982; Collinge 2001). When BSE was ﬁrst
described, it was immediately recognized as a member
of this group. There are powerful similarities between
BSE and kuru in that they are the only known examples
of an epidemic created by the oral intraspecies re-
cycling of infectious CNS material. The oral trans-
missibility of BSE to humans to cause vCJD provides
yet another link between kuru and BSE/vCJD.
In addition to the central historical importance of
kuru, the end stage of the kuru epidemic offers a unique
opportunity to study the parameters of a nearly
completed human prion disease epidemic and its
genetic and other determinants. In particular, recog-
nition of the extraordinary incubation periods possible
following natural prion infection of humans is import-
ant in providing an insight, from actual case histories
rather than mathematical models, into the likely span
of the vCJD epidemic in the UK. It was not possible to
estimate kuru incubation periods early in the epidemic
since the actual infecting event for an individual was
unknown, though the onset of disease in children as
young as 5 years gave a measure of the minimum
incubation period—it may have been less than 5 years
but it could not have been more. For the maximum
incubation period, we now have a new measure since
the abrupt and permanent interruption of the source of
infection, endocannibalism, in the late 1950s has
progressively allowed recognition of an enormous
span of possible incubations extending up to, and
perhaps beyond, the incubations of more than half a
century described here. The signiﬁcance of these
remarkable ﬁndings has recently been discussed in
detail (Collinge et al. 2006).
During our ﬁeld studies, we have obtained from
older people who participated in traditional mortuary
feasting explicit accounts of the practices and their
social and spiritual signiﬁcance. These detailed
descriptions will be published separately but reafﬁrmed
the oral histories of endocannibalism among the Fore
reported by a number of earlier investigators (Glasse
1967; Alpers 1968; Mathews et al. 1968; Gajdusek
1977; Lindenbaum 1979). Despite the importance of
spiritual cannibalism in religious observance and the
use of modern forms of cannibalism in organ and
tissue transplantation, the term ‘cannibalism’ and its
cognates have an unavoidable derogatory connotation.
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(Alpers 1999, 2005) for describing the mortuary
practice of consumption by family members of their
dead, as practised by the people of the kuru region to
incorporate the body of their loved one into the bodies
of the living and help to free the newly disembodied
spirit. This practice ceased abruptly when the people
ﬁrst came under Australian administrative control.
While isolated events may have occurred for a few years
after this prohibition, new exposures of individuals to
kuru at mortuary feasts would not have occurred after
1960. In fact, no patients with kuru have been recorded
who were born after 1959 (and only nine were recorded
in those born between 1956 and 1959); indeed, all of
the 11 recently recorded cases of kuru, reported here,
were born before 1950. Were there any remaining
source of infection, whether from surreptitious canni-
balism or possible ground contamination (Brown &
Gajdusek 1991), we would have expected to have had
kuru patients born after this period—particularly, as
children are thought to have had shorter incubation
periods—but this has not been observed. In addition,
no clusters of cases, as shown to have been the outcome
of the last family mortuary feasts celebrated in the area
(Klitzman et al. 1984), have been recorded for many
years. We found no evidence for maternal transmission
from the kuru archives, from colleagues who had
practised medicine in the area or from local oral history.
Again, any vertical route of kuru transmission, if it
existed, should also have resulted in the occurrence of
kuru cases in persons born after 1960, particularly
since kuru was common among women of childbearing
age; no such cases have occurred. We can therefore
conﬁdently attribute the persistence of the epidemic
beyond another four decades to long incubation
periods.
With respect to extrapolation to incubation periods
of BSE prion infection in humans, it is important to
recognize that the kuru epidemic arose from human-
to-human transmission. The transmission of prions
between different mammalian species is associated with
a barrier, originally termed a ‘species barrier’ (Pattison
1965) but better called a ‘transmission barrier’ in
recognition of the importance of within-species prion
strain type in addition to species-speciﬁc differences in
its determination (Collinge 1999). Such a transmission
barrier leads to prolongation of the mean incubation
period, an increase in the spread of incubation period
and a reduced attack rate in comparison with the 100%
mortality generally associated with within-species
inoculation with high-titre infectious material. Incu-
bation periods approaching the natural lifespan of the
inoculated species are often seen in primary cross-
species transmission of prions. The second and
subsequent passage of prions within the new species
is always associated with considerable shortening of the
mean and spread of incubation period and high or total
lethality to high-titre inocula. Indeed, transmission
barriers are quantiﬁed experimentally by measuring the
fall in incubation period between primary transmission
and subsequent passage in the new host, or by
comparison of LD50s (the dose causing 50% mortality)
between the two species by endpoint titration of
infectivity in the two species concerned. For this
reason, to estimate the range of possible incubation
periods of BSE infection of humans causing vCJD
requires superimposition of the effect of a transmission
barrier onto the ﬁndings of natural incubation periods
in human prion disease exempliﬁed by kuru.
The mean incubation period for kuru has been
estimated to be approximately 12 years (Collinge 1999)
and a similar estimate has been made in iatrogenic CJD
associated with the use of human cadaver-derived
pituitary growth hormone (Brown et al. 2000). As
evidenced here, in kuru, maximum incubation periods
can exceed 50 years. The cattle BSE-to-human
transmission barrier is unknown and cannot be directly
determined. However, the cattle-to-mouse barrier for
the BSE strain has been well characterized experimen-
tally by comparative endpoint titration. BSE prions
transmit readily to laboratory mice (Fraser et al.1 9 9 2 a),
including following oral dosing (Barlow & Middleton
1990). The murine LD50 (assayed in C57Bl/6 mice) is
approximately 500-fold higher than that in cattle
(Wells et al.1 9 9 8 ); this barrier also results in a three-
tofourfold increase inmean incubation period (Collinge
1999; Lloyd et al. 2002). Mean incubation periods of
human BSE infection of 30 years or more should
therefore be considered possible, if not probable
(Collinge 1999), with the longest incubation periods
approaching,and perhapsexceeding,thenormalhuman
lifespan.Theshortestincubation periodsinkuru wereof
the order of 5 years. Similarly in vCJD, although the
total clinical case load to date has been much smaller,
the youngest onsets have been at the age of 12 years or
more, providing an early estimate of a minimum
incubation period.
The importance of prion strain differences, host
genetics and their interaction makes prediction difﬁcult
across the spectrum of prion diseases. In mice, prion
disease follows a well-deﬁned course with a highly
distinctive and repeatable incubation time for a given
prion strain in a deﬁned inbred mouse line. In addition
to the PrP gene, a small number of additional genetic
loci with a major effect on incubation period have been
mapped (Stephenson et al. 2000; Lloyd et al. 2001,
2002). It can be anticipated that the human homol-
ogues of such loci may play a key role in human
susceptibility to prion disease, both following acciden-
tal human prion exposure and exposure to the BSE
agent. By deﬁnition, the patients identiﬁed to date with
vCJD are those with the shortest incubation periods for
BSE. It is possible that these patients received a
particularly high dose of BSE prions. However, no
unusual history of dietary, occupational or other
exposure to BSE has been reported from case–control
studies. Given the powerful genetic effects on incu-
bation period in laboratory animals, it is therefore
possible that the vCJD patients so far identiﬁed
represent a distinct genetic subpopulation with un-
usually short incubation periods to BSE prions, with
vCJD occurring predominantly in those individuals
with alleles for short incubation time at these multiple
genetic loci in addition to having the codon 129
methionine homozygous PRNP genotype. It is possible
therefore that a human BSE epidemic will be multi-
phasic, and that recent estimates of the size of the vCJD
epidemic based on uniform genetic susceptibility may
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et al. 2000; D’Aignaux et al. 2001). Genes involved in
species-barrier effects, which would further increase
both the mean and range of human BSE incubation
periods, are also likely to be relevant. In this context, it
will be difﬁcult to accurately model a human epidemic
until such modiﬁer loci are identiﬁed and their gene
frequencies in the population can be measured (Lloyd
et al. 2001).
Heterozygosity at PRNP codon 129 is a major
determinant of susceptibility to and incubation time of
the human prion diseases (Palmer et al. 1991; Collinge
et al. 1991, 1996a; Lee et al. 2001; Mead et al. 2003).
Unsurprisingly, most (8/10) of these recent kuru cases,
with prolonged incubation periods, were heterozygous.
We have previously reported that most elderly survivors
of exposure to traditional mortuary feasts are hetero-
zygous (Mead et al. 2003). Although the number of
patients in our study was necessarily small, there was
no evidence of association of kuru with PRNP
haplotype, HLA DQ7, ApoE or PRND alleles (Collinge
et al. 2006).
The spread of kuru began from an initial focus in
Uwami (ﬁgure 2) in the Keiagana, moved to Awande on
the boundary of North and South Fore and thence
north and south into the Fore. The Fore have had the
bulk of the cases, certainly in the period since
the investigation of the disease began in 1957. In the
peripheral areas, and particularly in those villages in
ﬁgure 2 with a history of kuru but no recorded cases
in the database, kuru was of less signiﬁcance or died out
quickly. The people of the kuru region form overlapping
endogamous groups and there is no inherent reason why
kuru should have spread in the way it did. This may
have happened by chance or owing to differences in the
transumption patterns between different clans and
linguistic groups or owing to differences in genetic
susceptibility. The mortuary practices are being studied
in detail and specimens taken for genetic analysis.
Although the genetic ﬁndings so far, as reported here,
show no inﬂuence on kuru, with the exception of the
effect of codon 129 heterozygosity on incubation period
(and possibly clinical duration), it is clear that other
genetic loci play a major role in the determination of
prion incubation periods in mice (Stephenson et al.
2000; Lloyd et al. 2001, 2002), and the human
homologues of such mouse loci may well also inﬂuence
kuru incubation periods. Through the current pro-
gramme of research in the ﬁeld, questions raised in the
early days of kuru research (Gajdusek et al.1 9 6 1 ; Glasse
1962; Mathews 1965; Alpers 1968; Mathews et al.
1968) may yet ﬁnd an answer.
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